Dermapharm Holding SE
XETRA:DMP

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
XETRA:DMP
Watchlist
Price: 34 EUR 8.63% Market Closed
Market Cap: 1.8B EUR
Have any thoughts about
Dermapharm Holding SE?
Write Note

Dermapharm Holding SE
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dermapharm Holding SE
Total Equity Peer Comparison

Comparables:
ATAI
BAYN
MRK
93M1
PSG

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Dermapharm Holding SE
XETRA:DMP
Total Equity
€551.6m
CAGR 3-Years
15%
CAGR 5-Years
17%
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Total Equity
$243m
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Total Equity
€35.7B
CAGR 3-Years
6%
CAGR 5-Years
-4%
CAGR 10-Years
6%
Merck KGaA
XETRA:MRK
Total Equity
€28.5B
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
10%
MPH Health Care AG
XETRA:93M1
Total Equity
€251m
CAGR 3-Years
8%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Total Equity
€39.8m
CAGR 3-Years
51%
CAGR 5-Years
-14%
CAGR 10-Years
N/A

See Also

What is Dermapharm Holding SE's Total Equity?
Total Equity
551.6m EUR

Based on the financial report for Jun 30, 2024, Dermapharm Holding SE's Total Equity amounts to 551.6m EUR.

What is Dermapharm Holding SE's Total Equity growth rate?
Total Equity CAGR 5Y
17%

Over the last year, the Total Equity growth was 6%. The average annual Total Equity growth rates for Dermapharm Holding SE have been 15% over the past three years , 17% over the past five years .

Back to Top